News

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women’s Health Initiative (WHI) hormone therapy trials
06/01/2023,
Serge Rozenberg
Serge Rozenberg
Religion, women’s health, and obstetrician-gynecologists  by Mahmoud F Fathalla, Giuseppe Benagiano, Joseph Schenker,
20/12/2022,
Serge Rozenberg
Serge Rozenberg
Artificially sweetened beverages and urinary incontinence-a secondary analysis of the Women’s Health Initiative Observational Study. Nancy E Ringel et al
13/12/2022,
Serge Rozenberg
Serge Rozenberg
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy
08/12/2022,
Serge Rozenberg
Serge Rozenberg
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
30/11/2022,
Serge Rozenberg
Serge Rozenberg
Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal: Secondary Analysis of a Randomized Clinical Trial
28/11/2022,
Serge Rozenberg
Serge Rozenberg

Next meeting

11/03/2023
Cognitive disorders, depression and work ability at the menopause.
docacces_symbol copy 2

Latest news

06/01/2023
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative (WHI) hormone therapy trials
docacces_symbol copy